Total tryptase levels indicate risk for systemic reactions to rush immunotherapy and mast cell activation

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 4, 2011, Pages 342-343.e6

  Vegh, Arthur B ^a   George, Kimberly C ^b   Lotfi Emran, Sahar ^b   Butler, Nicolette E ^a   Schwartz, Lawrence B ^b  

^a Puget Sound Allergy   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPTASE;

ALLERGIC REACTION; CELL ACTIVATION; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME RELEASE; FLUSHING; HUMAN; IMMUNOTHERAPY; LETTER; MAST CELL; NAUSEA; PRIORITY JOURNAL; PRURITUS; RISK FACTOR; SKIN CELL; SWELLING; URTICARIA;

EID: 79953294497     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.12.015     Document Type: Letter

References (8)

1. Sampson HA, Munoz-Furlong A, Campbell RL et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;391-397. (Pubitemid 43190153)
2. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006;451-463. (Pubitemid 44247540)
3. Schwartz LB, Min HK, Ren S, et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol. 2003;5667-5673. (Pubitemid 36617859)
4. Schwartz LB, Bradford TR, Rouse C, et al. Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis. J Clin Immunol. 1994;190-204. (Pubitemid 24182179)
5. Van der Linden P-WG, Hack CE, Poortman J, Vivié-Kipp YC, Struyvenberg A, Van der Zwan JK. Insect-sting challenge in 138 patients: Relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol. 1992;110-118.
6. Bonadonna P, Perbellini O, Passalacqua G, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;680-686.
7. Rueff F, Przybilla B, Bilo MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;1047-1054.
8. Rueff F, Przybilla B, Bilo MB, et al. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol. 2010;105-111.